Carrboro, NC, United States of America

T Kendall Harden

This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: T Kendall Harden. Retrieved from https://idiyas.com/inventor/t-kendall-harden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: T Kendall Harden: Innovator in Cholinergic Receptor Ligands

Introduction

T Kendall Harden is a notable inventor based in Carrboro, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel cholinergic receptor ligands. His work has implications for treating various disorders associated with cholinergic receptors.

Latest Patents

Harden holds a patent for "Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands." This invention discloses novel cholinergic receptor ligands and relates to the synthesis of substituted derivatives of aza-bridged bicyclic amines. These compounds are designed for use as muscarinic receptor ligands and include methods for regulating the function of specific cholinergic receptor subtypes. The patent also outlines methods for treating disorders associated with cholinergic receptors.

Career Highlights

Harden is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in his field. His work has garnered attention for its potential therapeutic applications.

Collaborations

Harden has collaborated with esteemed colleagues such as Myoung Goo Kim and Harold L Kohn, contributing to the advancement of research in cholinergic receptor ligands.

Conclusion

T Kendall Harden's innovative work in the development of cholinergic receptor ligands showcases his commitment to advancing medicinal chemistry. His contributions have the potential to impact the treatment of various disorders, highlighting the importance of his research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…